Steven Park

7PUBLICATIONS
35CO-AUTHORS
NanomaterialsCardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 28, 2024
Correction to "Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma".

Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin

|Sep 22, 2023
Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia.

Issam S Hamadeh, Jai N Patel, Ryan Jacobs

|Dec 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.

Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova

|Oct 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma.

Timothy J Voorhees, Beibo Zhao, Jorge Oldan

|Sep 14, 2020
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy.

Kin Man Au, Steven I Park, Andrew Z Wang

Pageof 2